In conclusion, after over an average of 7 years’ follow-up, our findings indicate that the combination of telmisartan and rosuvastatin might be an effective prevention and/or treatment strategy for cognitive impairment and dementia in hypertensive patients, especially in those with APOE ε4 allele. The gene discussed is APOE; the disease is dementia.